Endonovo Therapeutics annual revenue
2010
2011
2012
2014
2018
2019
2020
2021
2022
Endonovo Therapeutics Revenue Growth & History (ENDV)
Endonovo Therapeutics reported $135,355 in revenue for fiscal 2022, an increase of 85.15% from the previous fiscal year.
View full Endonovo Therapeutics company overviewEndonovo Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | $135,355 | $62,250 | +85.15% |
| 2021 | 2021-12-31 | $73,105 | −$92,691 | −55.91% |
| 2020 | 2020-12-31 | $165,796 | −$144,368 | −46.55% |
| 2019 | 2019-12-31 | $310,164 | $226,901 | +272.51% |
| 2018 | 2018-12-31 | $83,263 | $59,071 | +244.18% |
| 2014 | 2014-12-31 | $24,192 | −$6,389 | −20.89% |
| 2012 | 2012-12-31 | $30,581 | −$14,963 | −32.85% |
| 2011 | 2011-12-31 | $45,544 | −$5,655 | −11.05% |
| 2010 | 2010-12-31 | $51,199 | — | — |
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Primary source
SEC company filings
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Endonovo Therapeutics filings at SEC.gov ↗